http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021087839-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_806ea60b6f9611362a3c15a8f2360643 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-10 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47 |
| filingDate | 2019-11-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_718c92d53f20d1b4fa5b5deffa0be65c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_15c50eba959e9686d2cd670da5916e3b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8157dadc09466288277a816a8a8d18a7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_20687833550284f4cfe41b6d47008219 |
| publicationDate | 2021-05-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-2021087839-A1 |
| titleOfInvention | Tumor-specific polypeptide sequence and application thereof |
| abstract | Provided are a tumor-specific polypeptide sequence and an application thereof. The polypeptide comprises at least any polypeptide in a first peptide group, and can optionally comprise at least any polypeptide in a second peptide group. The first peptide group comprises polypeptides having the sequences shown in SEQ ID NO: 1 to SEQ ID NO: 5; the second peptide group comprises derived peptides having the sequences shown in SEQ ID NO: 1 to SEQ ID NO: 5. The derived peptides comprise front, middle and back peptide segments connected in sequence. The middle peptide segment has at least 80% homology with the sequences shown in SEQ ID NO:1 to SEQ ID NO:5, and the sum of the lengths of the front and back peptide segments is 14-16 amino acids. Also provided are an isolated nucleic acid, a construct, an expression vector, a pharmaceutical composition, an antigen presenting cell, an immune effector cell, a tumor vaccine, and use of the polypeptide in the preparation of a drug for preventing or treating a tumor and a method for treating a tumor patient. |
| priorityDate | 2019-11-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 126.